Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: Is it all set to irrefutable clinical translation?

Molecular Neurobiology

Volumn 45, Issue 1, 2012, Pages 186-199

  Singhal, Naveen Kumar ^a   Srivastava, Garima ^a   Agrawal, Sonal ^a   Jain, Swatantra Kumar ^b   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Melatonin; Neuroprotection; Parkinson's disease; Rodent models

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; DOPAMINE; MANEB; MELATONIN; METHAMPHETAMINE; OXIDOPAMINE; PARAQUAT; ROTENONE; UBIQUITIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRADYKINESIA; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; REVIEW; TREMOR;

EID: 84856721686     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-011-8225-x     Document Type: Review

References (131)

1. MP Singh S Patel M Dikshit YK Gupta 2006 Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease Indian J Biochem Biophys 43 69 81 16955754 1:CAS:528:DC%2BD28XmtFSltb0%3D (Pubitemid 44475398)
2. G Srivastava K Singh MN Tiwari MP Singh 2010 Proteomics in Parkinson's disease: current trends, translational snags and future possibilities Expert Rev Proteomics 7 127 139 20121482 1:CAS:528:DC%2BC3cXhtlOitbw%3D
3. R Betarbet TB Sherer JT Greenamyre 2002 Animal models of Parkinson's disease Bioessays 24 308 318 11948617 1:CAS:528:DC%2BD38XjsFWjtrc%3D (Pubitemid 34305686)
4. E Esposito S Cuzzocrea 2010 Antiinflammatory activity of melatonin in central nervous system Curr Neuropharmacol 8 228 242 21358973 1:CAS:528:DC%2BC3cXhtl2mtrvL
5. A Galano DX Tan RJ Reiter 2011 Melatonin as a natural ally against oxidative stress: a physicochemical examination J Pineal Res 51 1 16 21752095 1:CAS:528:DC%2BC3MXpslKqsro%3D
6. J Leon D Acuna-Castroviejo RM Sainz JC Mayo DX Tan RJ Reiter 2004 Melatonin and mitochondrial function Life Sci 75 765 790 15183071 1:CAS:528:DC%2BD2cXks1Cis70%3D (Pubitemid 38737416)
7. JC Mayo RM Sainz DX Tan I Antolín C Rodríguez RJ Reiter 2005 Melatonin and Parkinson's disease Endocrine 27 169 178 16217130 1:CAS:528:DC%2BD2MXhtFansLnJ (Pubitemid 41558449)
8. NK Singhal G Srivastava DK Patel SK Jain MP Singh 2011 Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse J Pineal Res 50 97 109 20964710 1:CAS:528:DC%2BC3MXivF2ksr0%3D
9. C Rodriguez JC Mayo RM Sainz I Antolín F Herrera V Martín RJ Reiter 2004 Regulation of antioxidant enzymes: a significant role for melatonin J Pineal Res 36 1 9 14675124 1:CAS:528:DC%2BD2cXotFKltQ%3D%3D (Pubitemid 38130283)
10. J Leon D Acuna-Castroviejo G Escames DX Tan RJ Reiter 2005 Melatonin mitigates mitochondrial malfunction J Pineal Res 38 1 9 15617531 1:CAS:528:DC%2BD2MXpsFekug%3D%3D (Pubitemid 40139304)
11. V Srinivasan SR Pandi-Perumal GJ Maestroni AI Esquifino R Hardeland DP Cardinali 2005 Role of melatonin in neurodegenerative diseases Neurotox Res 7 293 318 16179266 1:CAS:528:DC%2BD28XhtFKqsbbP
12. YK Gupta M Gupta K Kohli 2003 Neuroprotective role of melatonin in oxidative stress vulnerable brain Indian J Physiol Pharmacol 47 373 386 15266948 1:CAS:528:DC%2BD3sXotl2jtLk%3D (Pubitemid 37151175)
13. G Escames A Lopez JA Garcia L Garcia D Acuna-Castroviejo JJ Garcia LC Lopez 2010 The role of mitochondria in brain aging and the effects of melatonin Curr Neuropharmacol 8 182 193 21358969 1:CAS:528:DC%2BC3cXhtl2mtrvP
14. A Borah KP Mohanakumar 2009 Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental Parkinsonism in rodents J Pineal Res 47 293 300 19796048 1:CAS:528:DC%2BD1MXhtlOqtLjF
15. S Klongpanichapak P Phansuwan-Pujito M Ebadi P Govitrapong 2008 Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells Neurosci Lett 436 309 313 18406059 1:CAS:528:DC%2BD1cXls1Shtb0%3D
16. RJ Reiter DX Tan MJ Jou A Korkmaz LC Manchester SD Paredes 2008 Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites Neuro Endocrinol Lett 29 391 398 18766165
17. V Tapias G Escames LC López A Lopez E Camacho MD Carrión A Entrena MA Gallo A Espinosa D Acuña-Castroviejo 2009 Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice J Neurosci Res 87 3002 3010 19437546 1:CAS:528:DC%2BD1MXhtVSntbrP
18. JE Jan RJ Reiter PK Wong MC Bax U Ribary MB Wasdell 2011 Melatonin has membrane receptor-independent hypnotic action on neurons: an hypothesis J Pineal Res 50 233 240 21210841 1:CAS:528:DC%2BC3MXjs1Gltrw%3D
19. KJ Kwon JN Kim MK Kim J Lee LJ Ignarro HJ Kim CY Shin SH Han 2011 Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection J Pineal Res 50 110 123 21073519 1:CAS:528:DC%2BC3MXivF2ksro%3D
20. MD Catala C Canete-Nicolas A Iradi PJ Tarazona JM Tormos A Pascual-Leone 1997 Melatonin levels in Parkinson's disease: drug therapy versus electrical stimulation of the internal globus pallidus Exp Gerontol 32 553 558 9315456 1:CAS:528:DyaK2sXmtVGhtr0%3D (Pubitemid 27366490)
21. CA Medeiros PF Carvalhedo de Bruin LA Lopes MC Magalhaes SM de Lourdes VM de Bruin 2007 Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study J Neurol 254 459 464 17404779 1:CAS:528:DC%2BD2sXlvF2isrw%3D (Pubitemid 46786720)
22. M Thiruchelvam EK Richfield BM Goodman RB Baggs DA Cory-Slechta 2002 Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype Neurotoxicology 23 621 633 12428734 1:CAS:528: DC%2BD38XnvVGrtbg%3D (Pubitemid 36527682)
23. J Bove D Prou C Perier S Przedborski 2005 Toxin-induced models of Parkinson's disease NeuroRx 2 484 494 16389312 (Pubitemid 41444882)
24. E Croisier LB Moran DT Dexter RK Pearce MB Graeber 2005 Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition J Neuroinflammation 2 14 15935098
25. Y Glinka M Gassen MB Youdim 1997 Mechanism of 6-hydroxydopamine neurotoxicity J Neural Transm Suppl 50 55 66 9120425 1:STN:280: DyaK2s7ptFKrtA%3D%3D (Pubitemid 27055928)
26. A Schober 2004 Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP Cell Tissue Res 318 215 224 15503155 (Pubitemid 39366054)
27. VN Uversky 2004 Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration Cell Tissue Res 318 225 241 15258850 1:CAS:528: DC%2BD2cXos1aqsLk%3D (Pubitemid 39362642)
28. JC Mayo RM Sainz I Antolín C Rodriguez 1999 Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage Brain Res 818 221 227 10082807 1:CAS:528:DyaK1MXnslOqsg%3D%3D (Pubitemid 29229935)
29. YS Kim WS Joo BK Jin YH Cho HH Baik CW Park 1998 Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system Neuroreport 9 2387 2390 9694233 1:CAS:528:DyaK1cXltVKltL4%3D (Pubitemid 28338239)
30. WS Joo BK Jin CW Park SH Maeng YS Kim 1998 Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats Neuroreport 9 4123 4126 9926859 1:CAS:528:DyaK1MXpvFSktg%3D%3D (Pubitemid 29030700)
31. F Dabbeni-Sala S Di Santo D Franceschini SD Skaper P Giusti 2001 Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity FASEB J 15 164 170 11149904 1:CAS:528:DC%2BD3MXht1Snsb4%3D (Pubitemid 32061667)
32. LM Aguiar SM Vasconcelos FC Sousa GS Viana 2002 Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum Life Sci 70 1041 1051 11862988 1:CAS:528:DC%2BD38XovVWitA%3D%3D (Pubitemid 34086948)
33. JC Mayo RM Sainz H Uria I Antolin MM Esteban C Rodriguez 1998 Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease J Pineal Res 24 179 192 9551855 1:CAS:528: DyaK1cXhvFSisr0%3D (Pubitemid 28156603)
34. GL Willis SM Armstrong 1999 A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease Physiol Behav 66 785 795 10405106 1:CAS:528:DyaK1MXktlGju7k%3D (Pubitemid 29281640)
35. S Singh R Ahmed RK Sagar B Krishana 2006 Neuroprotection of the nigrostriatal dopaminergic neurons by melatonin in hemiparkinsonium rat Indian J Med Res 124 419 426 17159262 1:CAS:528:DC%2BD2sXht1als7c%3D (Pubitemid 46603377)
36. RL Miller M James-Kracke GY Sun AY Sun 2009 Oxidative and inflammatory pathways in Parkinson's disease Neurochem Res 34 55 65 18363100 1:CAS:528:DC%2BD1MXktVejtw%3D%3D
37. JW Langston P Ballard JW Tetrud I Irwin 1983 Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 979 980 6823561 1:STN:280:DyaL3s7hvF2mtg%3D%3D (Pubitemid 13189531)
38. JW Langston LS Forno J Tetrud AG Reeves JA Kaplan D Karluk 1999 Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure Ann Neurol 46 598 605 10514096 1:CAS:528:DyaK1MXmvVGitbg%3D (Pubitemid 29466438)
39. HM Gao B Liu W Zhang JS Hong 2003 Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease FASEB J 17 1954 1956 12897068 1:CAS:528:DC%2BD3sXot1KitL8%3D
40. Y Kotake S Ohta 2003 MPP+ analogs acting on mitochondria and inducing neuro-degeneration Curr Med Chem 10 2507 2516 14529466 1:CAS:528: DC%2BD3sXpt1Kmsb0%3D (Pubitemid 37456021)
41. E Absi A Ayala A Machado J Parrado 2000 Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain J Pineal Res 29 40 47 10949539 1:CAS:528:DC%2BD3cXltl2ht70%3D (Pubitemid 30449700)
42. BK Jin DY Shin MY Jeong MR Gwag HW Baik KS Yoon YH Cho WS Joo YS Kim HH Baik 1998 Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats Neurosci Lett 245 61 64 9605485 1:CAS:528:DyaK1cXhvFKiu7s%3D (Pubitemid 28194883)
43. RJ Reiter 1998 Oxidative damage in the central nervous system: protection by melatonin Prog Neurobiol 56 359 384 9770244 1:CAS:528:DyaK1cXmtFKhtbc%3D (Pubitemid 28389724)
44. D Acuna-Castroviejo A Coto-Montes M Gaia Monti GG Ortiz RJ Reiter 1997 Melatonin is protective against MPTP-induced striatal and hippocampal lesions Life Sci 60 PL23 PL29 9000122 1:CAS:528:DyaK28XnsFSgsb4%3D
45. C Capitelli A Sereniki MM Lima AB Reksidler S Tufik MA Vital 2008 Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats Eur J Pharmacol 594 101 108 18674531 1:CAS:528: DC%2BD1cXhtVynurzK
46. I Antolín JC Mayo RM Sainz ML del Brío F Herrera V Martín C Rodríguez 2002 Protective effect of melatonin in a chronic experimental model of Parkinson's disease Brain Res 943 163 173 12101038 (Pubitemid 36120376)
47. J Ma VE Shaw J Mitrofanis 2009 Does melatonin help save dopaminergic cells in MPTP-treated mice? Parkinsonism Relat Disord 15 307 314 18793863
48. R Niranjan C Nath R Shukla 2010 The mechanism of action of MPTP-induced neuroinflammation and its modulation by melatonin in rat astrocytoma cells, C6 Free Radic Res 44 1304 1316 20815783 1:CAS:528:DC%2BC3cXht1yjsrrF
49. XJ Li J Gu SD Lu FY Sun 2002 Melatonin attenuates MPTP-induced dopaminergic neuronal injury associated with scavenging hydroxyl radical J Pineal Res 32 47 52 11841600 (Pubitemid 34123756)
50. JY Huang JI Chuang 2010 Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma-glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity Free Radic Biol Med 49 1099 1108 20615462 1:CAS:528:DC%2BC3cXhtVeksrjK
51. JI Chuang TH Chen 2004 Effect of melatonin on temporal changes of reactive oxygen species and glutathione after MPP(+) treatment in human astrocytoma U373MG cells J Pineal Res 36 117 125 14962063 1:CAS:528: DC%2BD2cXhs1Sru7k%3D
52. B Thomas KP Mohanakumar 2004 Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum J Pineal Res 36 25 32 14675127 1:CAS:528:DC%2BD2cXotFKksg%3D%3D (Pubitemid 38130286)
53. ST Chen JI Chuang MH Hong EI Li 2002 Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway J Pineal Res 32 262 269 11982797 1:CAS:528:DC%2BD38XktlWjtL4%3D
54. GG Ortiz ME Crespo-López C Moran-Moguel JJ García RJ Reiter D Acuna-Castroviejo 2001 Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo Neuro Endocrinol Lett 22 101 108 11335886 1:CAS:528:DC%2BD3MXjslKgurg%3D (Pubitemid 32396388)
55. J Chetsawang P Govitrapong B Chetsawang 2007 Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells J Pineal Res 43 115 120 17645689 1:CAS:528:DC%2BD2sXovFant7o%3D (Pubitemid 47077216)
56. L Iacovitti ND Stull K Johnston 1997 Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress Brain Res 768 317 326 9369331 1:CAS:528:DyaK2sXlslelt7k%3D (Pubitemid 27433507)
57. CJ Van der Schyf K Castagnoli S Palmer L Hazelwood N Castagnoli Jr 2000 Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum Neurotox Res 1 261 269 12835094
58. N Simon K Papa J Vidal A Boulamery B Bruguerolle 2003 Circadian rhythms of oxidative phosphorylation: effects of rotenone and melatonin on isolated rat brain mitochondria Chronobiol Int 20 451 461 12868540 1:CAS:528: DC%2BD3sXmtFGgurg%3D (Pubitemid 36828478)
59. AL McCormack M Thiruchelvam AB Manning-Bog C Thiffault JW Langston DA Cory-Slechta DA Di Monte 2002 Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat Neurobiol Dis 10 119 217 12127150 1:CAS:528: DC%2BD38XltFyrtbs%3D
60. S Patel V Singh A Kumar YK Gupta MP Singh 2006 Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration Brain Res 1081 9 18 16510128 1:CAS:528:DC%2BD28XjsFOnurs%3D
61. S Patel A Sinha MP Singh 2007 Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse Neurotoxicol Teratol 29 578 585 17532186 1:CAS:528:DC%2BD2sXht1aksLbI (Pubitemid 47599875)
62. S Patel K Singh S Singh MP Singh 2008 Gene expression profiles of mouse striatum in control and maneb + paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts Mol Biotechnol 40 59 68 18386188 1:CAS:528:DC%2BD1cXhtVKntb%2FM
63. J Peng FF Stevenson SR Doctrow JK Andersen 2005 Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease J Biol Chem 80 29194 29198 (Pubitemid 41161371)
64. K Shimizu K Matsubara K Ohtaki H Shiono 2003 Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture Neurosci Res 46 523 532 12871774 1:CAS:528:DC%2BD3sXlsVaitLc%3D (Pubitemid 36842803)
65. M Thiruchelvam EK Richfield RB Baggs AW Tank DA Cory-Slechta 2000 The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease J Neurosci 20 9207 9214 11124998 1:CAS:528:DC%2BD3MXis1Wiuw%3D%3D (Pubitemid 32042923)
66. E Bonilla S Medina-Leendertz V Villalobos L Molero A Bohorquez 2006 Paraquat-induced oxidative stress in Drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid Neurochem Res 31 1425 1432 17086442 1:CAS:528:DC%2BD28Xht1OhtrfJ (Pubitemid 44900582)
67. DX Tan LC Manchester RM Sainz JC Mayo J Leon R Hardeland B Poeggeler RJ Reiter 2005 Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin J Pineal Res 39 185 194 16098097 1:CAS:528:DC%2BD2MXovFSjtr0%3D (Pubitemid 41140758)
68. D Melchiorri GG Ortiz RJ Reiter E Sewerynek WM Daniels MI Pablos G Nisticò 1998 Melatonin reduces paraquat-induced genotoxicity in mice Toxicol Lett 95 103 108 9635413 1:CAS:528:DyaK1cXivVKhtbw%3D
69. HA Yamamoto PV Mohanan 2001 Effects of melatonin on paraquat or ultraviolet light exposure-induced DNA damage J Pineal Res 31 308 313 11703559 1:CAS:528:DC%2BD3MXotlCnt70%3D (Pubitemid 33032945)
70. D Melchiorri RJ Reiter E Sewerynek M Hara L Chen G Nistico 1996 Paraquat toxicity and oxidative damage. Reduction by melatonin Biochem Pharmacol 51 1095 1099 8866832 1:CAS:528:DyaK28XitVOmt7o%3D
71. M Ishido 2007 Melatonin inhibits maneb-induced aggregation of alpha-synuclein in rat pheochromocytoma cells J Pineal Res 42 125 130 17286743 1:CAS:528:DC%2BD2sXitlygsbo%3D (Pubitemid 46233057)
72. CH Lin JY Huang CH Ching JI Chuang 2008 Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats J Pineal Res 44 205 213 18289173 1:CAS:528:DC%2BD1cXjtFCgur0%3D
73. V Tapias JR Cannon JT Greenamyre 2010 Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model J Neurosci Res 88 420 427 19681169 1:CAS:528:DC%2BD1MXhsFensb3K
74. KS Saravanan KM Sindhu KP Mohanakumar 2007 Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model J Pineal Res 42 247 253 17349022 1:CAS:528:DC%2BD2sXltFCntbc%3D (Pubitemid 46365061)
75. H Coulom S Birman 2004 Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster J Neurosci 24 10993 10998 15574749 1:CAS:528:DC%2BD2cXhtFShu77F (Pubitemid 39602410)
76. SC Sousa RF Castilho 2005 Protective effect of melatonin on rotenone plus Ca2+-induced mitochondrial oxidative stress and PC12 cell death Antioxid Redox Signal 7 1110 1116 16115015 1:CAS:528:DC%2BD2MXos1eqsr4%3D (Pubitemid 41232507)
77. M Gerlach P Reiderer 1996 Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man J Neural Transm 103 987 1041 9013391 1:CAS:528:DyaK28XntVKku7Y%3D (Pubitemid 26383833)
78. A Virmani F Gaetani S Imam Z Binienda S Ali 2002 The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction Ann N Y Acad Sci 965 225 232 12105098 1:CAS:528:DC%2BD38XlvVOjt7s%3D (Pubitemid 34721970)
79. M Asanuma T Hayashi SV Ordonez N Ogawa JL Cadet 2000 Direct interactions of METH with the nucleus Mol Brain Res 80 237 243 11038257 1:CAS:528: DC%2BD3cXmtF2qtrs%3D
80. SZ Imam J el-Yazal GD Newport Y Itzhak JL Cadet W Slikker Jr SF Ali 2001 Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts Ann N Y Acad Sci 939 366 380 11462792 1:CAS:528:DC%2BD3MXlsV2ksLk%3D (Pubitemid 32620088)
81. C Nopparat JE Porter M Ebadi P Govitrapong 2010 The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy J Pineal Res 49 382 389 20738755 1:CAS:528:DC%2BC3cXhsVWgurbK
82. Y Itzhak JL Martin MD Black SF Ali 1998 Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization Neuropharmacology 37 781 791 9707292 1:CAS:528:DyaK1cXkvVCltbk%3D (Pubitemid 28313903)
83. W Wang C Ma Z Mao M Li 2004 JNK inhibition as a potential strategy in treating Parkinson's disease Drug News Perspect 17 646 654 15696229 1:CAS:528:DC%2BD2MXjt12lsb4%3D (Pubitemid 40224050)
84. S Klongpanichapak P Phansuwan-Pujito M Ebadi P Govitrapong 2007 Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity J Pineal Res 43 65 73 17614837 1:CAS:528:DC%2BD2sXosFCjt7c%3D (Pubitemid 47035223)
85. J Tocharus C Khonthun S Chongthammakun P Govitrapong 2010 Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines J Pineal Res 48 347 352 20374443 1:CAS:528: DC%2BC3cXltFSltbs%3D
86. W Suwanjang P Phansuwan-Pujito P Govitrapong B Chetsawang 2010 The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells J Pineal Res 48 94 101 20050990 1:CAS:528:DC%2BC3cXitFCls7o%3D
87. W Wisessmith P Phansuwan-Pujito P Govitrapong B Chetsawang 2009 Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells J Pineal Res 46 433 440 19386024 1:CAS:528:DC%2BD1MXlsFSqsr4%3D
88. P Kongsuphol S Mukda C Nopparat A Villarroel P Govitrapong 2009 Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells J Pineal Res 46 199 206 19054297 1:CAS:528:DC%2BD1MXit1Gqurg%3D
89. S Kaewsuk K Sae-ung P Phansuwan-Pujito P Govitrapong 2009 Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain Neurochem Int 55 397 405 19409439 1:CAS:528:DC%2BD1MXoslSju7g%3D
90. H Hirata M Asanuma JL Cadet 1998 Melatonin attenuates methamphetamine-induced toxic effects on dopamine and serotonin terminals in mouse brain Synapse 30 150 155 9723784 1:CAS:528:DyaK1cXlsVShurY%3D (Pubitemid 28376373)
91. JW Gibb L Bush GR Hanson 1997 Exacerbation of methamphetamine-induced neurochemical deficits by melatonin J Pharmacol Exp Ther 283 630 635 9353379 1:CAS:528:DyaK2sXnsV2ms78%3D (Pubitemid 27514620)
92. S Mukda O Vimolratana P Govitrapong 2011 Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum Neurosci Lett 488 154 157 21078367 1:CAS:528: DC%2BC3MXhs1GhtQ%3D%3D
93. J Tocharus S Chongthammakun P Govitrapong 2008 Melatonin inhibits amphetamine-induced nitric oxide synthase mRNA overexpression in microglial cell lines Neurosci Lett 439 134 137 18524487 1:CAS:528:DC%2BD1cXmvVKksrk%3D
94. A Kumar I Ahmad S Shukla BK Singh DK Patel HP Pandey C Singh 2010 Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats Free Radic Res 44 950 965 20553223 1:CAS:528:DC%2BC3cXhtVClu73J
95. Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2012) Long-term exposure to cypermethrin induces the nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33:404-415
96. AK Singh MN Tiwari A Dixit G Upadhyay DK Patel D Singh O Prakash MP Singh 2011 Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation dependent and independent regulations Toxicol Sci 122 526 538 21561882 1:CAS:528:DC%2BC3MXhtVeitbrI
97. MN Tiwari AK Singh I Ahmad G Upadhyay D Singh DK Patel C Singh O Prakash MP Singh 2010 Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system Free Radic Res 44 1416 1424 20815782 1:CAS:528:DC%2BC3cXhtlOhsr%2FF
98. SO Bachurin EP Shevtsova EG Kireeva GF Oxenkrug SO Sablin 2003 Mitochondria as a target for neurotoxins and neuroprotective agents Ann N Y Acad Sci 993 334 344 12853325 1:CAS:528:DC%2BD3sXmtVajsLs%3D (Pubitemid 36808462)
99. JW Miller J Selhub JA Joseph 1996 Oxidative damage caused by free radicals produced during catecholamine autoxidation: protective effects of O-methylation and melatonin Free Radic Biol Med 21 241 249 8818640 1:CAS:528:DyaK28XksFKqtrY%3D (Pubitemid 26255201)
100. R Sandyk 1990 Pineal melatonin functions: possible relevance to Parkinson's disease Int J Neurosci 50 37 53 2269599 1:STN:280: DyaK3M7gtVWntw%3D%3D
101. GL Willis 2008 Intraocular microinjections repair experimental Parkinson's disease Brain Res 1217 119 131 18502399 1:CAS:528: DC%2BD1cXnsFCqsrc%3D
102. RJ Reiter RC Carneiro CS Oh 1997 Melatonin in relation to cellular antioxidative defense mechanisms Horm Metab Res 29 363 372 9288572 1:CAS:528:DyaK2sXlsFGrtbk%3D (Pubitemid 27362059)
103. R Sandyk 1990 The significance of eye blink rate in Parkinsonism: a hypothesis Int J Neurosci 51 99 103 2265915 1:STN:280:DyaK3M%2Fpt1Okuw%3D%3D
104. GA Dowling J Mastick E Colling JH Carter CM Singer MJ Aminoff 2005 Melatonin for sleep disturbances in Parkinson's disease Sleep Med 6 459 466 16084125 (Pubitemid 41245369)
105. DX Tan RJ Reiter LC Manchester MT Yan M El-Sawi RM Sainz JC Mayo R Kohen M Allegra R Hardeland 2002 Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger Curr Top Med Chem 2 181 197 11899100 1:CAS:528:DC%2BD38XhvVaqu7Y%3D
106. H Khaldy G Escames J León F Vives JD Luna D Acuña- Castroviejo 2000 Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro J Pineal Res 29 100 107 10981823 1:CAS:528: DC%2BD3cXmtlejtb8%3D
107. H Khaldy G Escames J Leon L Bikjdaouene D Acuña-Castroviejo 2003 Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion Neurobiol Aging 24 491 500 12600724 1:CAS:528:DC%2BD3sXhsVanur8%3D (Pubitemid 36205054)
108. S Chakravarty SI Rizvi 2011 Circadian modulation of sodium-potassium ATPase and sodium-proton exchanger in human erythrocytes: in vitro effect of melatonin Cell Mol Biol 57 80 86 21366966 1:CAS:528:DC%2BC3MXjtFajtbY%3D Noisy-le-grand
109. S Chakravarty SI Rizvi 2011 Day and night GSH and MDA levels in healthy adults and effects of different doses of melatonin on these parameters Int J Cell Biol 2011 404591 21647290
110. O Weinreb S Mandel MB Youdim 2003 Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate, and melatonin Ann N Y Acad Sci 993 351 361 12853328 1:CAS:528:DC%2BD3sXmtVajsLg%3D (Pubitemid 36808465)
111. F Lezoualc'h M Sparapani C Behl 1998 N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB J Pineal Res 24 168 178 9551854 (Pubitemid 28156602)
112. D Roy DD Belsham 2002 Melatonin receptor activation regulates GnRH gene expression and secretion in GT1-7 GnRH neurons. Signal transduction mechanisms J Biol Chem 277 251 258 11684691 1:CAS:528:DC%2BD38XjslGjtg%3D%3D (Pubitemid 34952052)
113. D Kim J Chung 2002 Akt: versatile mediator of cell survival and beyond J Biochem Mol Biol 35 106 115 16248975 1:CAS:528:DC%2BD38XhtlWmu78%3D (Pubitemid 35216586)
114. PJ Kong JS Byun SY Lim JJ Lee SJ Hong KJ Kwon SS Kim 2008 Melatonin induces Akt phosphorylation through melatonin receptor- and PI3K-dependent pathways in primary astrocytes Korean J Physiol Pharmacol 12 37 41 20157392 1:CAS:528:DC%2BD1cXntFOrurs%3D
115. SH Lee W Chun PJ Kong JA Han BP Cho OY Kwon HJ Lee SS Kim 2006 Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus J Pineal Res 40 79 85 16313502 1:CAS:528:DC%2BD28Xhs1Gnu78%3D
116. U Kilic E Kilic RJ Reiter CL Bassetti DM Hermann 2005 Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice J Pineal Res 38 67 71 15617539 1:CAS:528:DC%2BD2MXpsFertA%3D%3D (Pubitemid 40139312)
117. R Sharma CR McMillan CC Tenn LP Niles 2006 Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease Brain Res 1068 230 236 16375867 1:CAS:528:DC%2BD28Xos1Wrsg%3D%3D (Pubitemid 43139282)
118. LP Niles KJ Armstrong LM Rincón Castro CV Dao R Sharma CR McMillan LC Doering DL Kirkham 2004 Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers BMC Neurosci 5 41 15511288
119. KJ Armstrong LP Niles 2002 Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells Neuroreport 13 473 475 11930164 1:CAS:528: DC%2BD38XnsFKku7s%3D (Pubitemid 34293193)
120. N Adi DC Mash Y Ali C Singer L Shehadeh S Papapetropoulos 2010 Melatonin MT1 and MT2 receptor expression in Parkinson's disease Med Sci Monit 16 BR61 BR67 20110911 1:CAS:528:DC%2BC3cXktF2mur4%3D
121. N Buscemi B Vandermeer N Hooton R Pandya L Tjosvold L Hartling G Baker TP Klassen S Vohra 2005 The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis J Gen Intern Med 20 1151 1158 16423108 (Pubitemid 43110268)
122. N Buscemi B Vandermeer N Hooton R Pandya L Tjosvold L Hartling S Vohra TP Klassen G Baker 2006 Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis BMJ 332 385 393 16473858 1:CAS:528:DC%2BD28XisFGqsr0%3D
123. GA Bubenik SJ Konturek 2011 Melatonin and aging: prospects for human treatment J Physiol Pharmacol 62 13 19 21451205 1:CAS:528:DC%2BC3MXmtFagsrg%3D
124. EC Lauterbach J Victoroff KL Coburn SD Shillcutt SM Doonan MF Mendez 2010 Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data J Neuropsychiatry Clin Neurosci 22 8 18 20160205 1:CAS:528:DC%2BC3cXjt1aiu74%3D
125. E Schernhammer H Chen B Ritz 2006 Circulating melatonin levels: possible link between Parkinson's disease and cancer risk? Cancer Causes Control 17 577 582 16596313
126. TA Zesiewicz ML Evatt 2009 Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease CNS Drugs 23 817 835 19739693 1:CAS:528:DC%2BD1MXhsVOgtr7F
127. R Sharma CR Mcmillan LP Niles 2007 Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease J Pineal Res 43 245 254 17803521 1:CAS:528:DC%2BD2sXhtFKjt7bI (Pubitemid 47353003)
128. D Acuna Castroviejo LC López G Escames A Lopez JA Garcia RJ Reiter 2011 Melatonin-mitochondria interplay in health and disease Curr Top Med Chem 11 221 240 21244359
129. MJ Jou TI Peng LF Hsu SB Jou RJ Reiter CM Yang CC Chiao YF Lin CC Chen 2010 Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2+)-mediated permeability transition and beyond in rat brain astrocytes J Pineal Res 48 20 38 19925580 1:CAS:528:DC%2BD1MXhs1WhtLzK
130. S Suzen 2006 Recent developments of melatonin related antioxidant compounds Comb Chem High Throughput Screen 9 409 419 16842222 1:CAS:528:DC%2BD28XmvVCgu7c%3D (Pubitemid 44024698)
131. CC Chiueh T Andoh AR Lai E Lai G Krishna 2000 Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals Neurotox Res 2 293 310 16787846 1:CAS:528:DC%2BD3cXot1Cqs7Y%3D